Enliven Therapeutics Inc.

18.69
-1.34 (-6.69%)
At close: Apr 04, 2025, 3:59 PM
18.56
-0.71%
After-hours: Apr 04, 2025, 04:24 PM EDT

Enliven Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
-89.02M -71.58M -37.66M -24.74M -18.97M -23.46M -11.34M n/a
317K 297K 215K 115K 45K 33K n/a n/a
20.17M 12.91M 3.19M 1.92M 130K 899K 555K n/a
-5.35M 3.65M 27K 1.83M 292K -77K 758K 478K
-118K -4.3M 1.74M 3.81M 9.68M 196K 848K -7.93M
n/a n/a n/a -3.81M n/a -215K n/a n/a
-4.54M 1.4M 438K 3.57M 583K 673K 1.24M -188K
-73.19M -61.27M -32.08M -19.13M -8.53M -21.88M -8.78M -8.79M
-44K -149K -612K -191K -461K -140K n/a n/a
n/a n/a 35M n/a n/a n/a n/a n/a
-350.74M -268.26M -35M -47.56M -64.2M -23.92M n/a n/a
313.91M 120M 41.88M 45.94M 47.5M n/a n/a n/a
873K n/a -41.88M 1.62M 16.7M n/a n/a n/a
-36M -148.41M -612K -191K -461K -24.06M n/a n/a
n/a n/a n/a n/a n/a -2M n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
93.98M 234.29M -1.8M -1.02M 130.51M n/a 6.49M 11M
133.16M 234.29M -1.8M -1.02M 130.51M 43.58M 6.49M 11M
23.98M 24.61M -34.49M -20.34M 121.52M -2.45M -2.29M 2.21M
-73.24M -61.42M -32.69M -19.32M -8.99M -22.02M -8.78M -8.79M